The Role of Biologically Active Aqueous Humor Molecules of the Anterior Chamber and Lacrimal Fluid in the Implementation of the Hypotensive Effect of Non-Penetrating Deep Sclerectomy

To date, the factors affecting the course of the reparative process after non-penetrating deep sclerectomy (NPDS) have not been fully determined. There is no systematic information about the regulatory role of the cytokines TGF-β, IL-6, IL-8 and MMP-9, VEGF A 121 and 165 in the formation mechanisms of the newly created pathways consistency of intraocular aqueous humor outflow.

Purpose. To determine possible ways of impact of biologically active aqueous humor molecules of the anterior chamber and lacrimal fluid on the hypotensive effect of non-penetrating deep sclerectomy.

Methods. A prospective study of 65 patients with open-angle glaucoma before and 12 months after NPDS and 22 patients without eye hydrodynamic disorders with the determination of the initial concentrations of biologically active molecules in the lacrimal fluid and aqueous humor of the anterior chamber. Twelve months after NPDS all patients were divided into three groups, depending on the hypotensive effect of the operation, according to the criteria.

Results. Multivariate discriminant analysis showed the greatest inter-group differences, calculated by the square of the Mahalanobis distance, between group 3 with no hypotensive effect of NPDS and the control group (R2 = 8.48, p = 0.001). The most informative features that determine the differences between the 4 groups in the total population, calculated according to the Fischer F-test, were MMP-9 (F = 14.7, p = 0.001) and TGF-β (F = 7.08, p = 0.001) in the aqueous humor of the anterior chamber. In pairwise comparison of groups 1 and 2, the maximum level of significance according to the F-criterion was characteristic of the level of tear IL-6 (F = 21.25, p = 0.001), with approximately equal degree – IL-8 (F = 7.85, p = 0.001) and VEGF (F = 7.12, p = 0.001), to a lesser extent TGF of aqueous humor (F = 4.43, p = 0.001) and MMR-9 (F = 2.23, p = 0.001). Between groups 1–3, the maximum differences according to the Fisher criterion were observed in the IL-8 (F = 20.99, p = 0.001), TGF (F = 8.75, p = 0.001) and to a lesser extent – TGF (F = 5.83, p = 0.001).

Conclusion. The analysis of the obtained data showed the decisive role of the imbalance of proinflammatory cytokines, signaling proteins with prolymphoangiogenic activity, and MMP-9 in the aqueous humor of the anterior chamber, as well as in the initial state of the lacrimal fluid in the postoperative healing processes after NPDS. 

1. Kurysheva HI, Marnykh SA, Borzinok SA, Bochkarev MV, Dolgina EN, Kizeev MV. Use of physiological reparation regulators in glaucoma surgery: A clinical immunological study. The Russian Annals of Ophthalmology. 2005; 121(6): 21-25. (In Russ.)

2. Volkova NV, Shchuko AG, Malyshev VV. Retrospective analysis of risk factors of intraocular fluid outflow pathways scar development after fistulasing antiglaucomatous surgery. Report 1. National Journal Glaucoma. 2010; 3: 35-40. (In Russ.)

3. Volkova NV, Shchuko AG, Malysheva UV, Iureva TN. Inadequate reparative regeneration in fistulazing glaucoma surgery. Fyodorov Journal of Ophthalmic Surgery. 2014; 3: 60- 66. (In Russ.)

4. Chang MR, Cheng Q, Lee DA. Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther. 1998; 14(1): 75-95. doi: 10.1089/jop.1998.14.75

5. Chang L, Crowston JG, Cordeiro MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthtalmol. 2000; 45(1): 49-68. doi: 10.1016/s0039-6257(00)00135-1

6. Titov VN. The significance of macrophages in the onset of inflammation; the effects of interleukin-1, interleukin-6 and the activity of hypothalamo-hypophysis system (a survey). Russian Clinical Laboratory Diagnostics. 2003; 12: 3-10. (In Russ.)

7. Reynolds AC, Skuta GL. Clinical perspectives on glaucoma filtrering surgery. Antiproliferative agents. Ophthalmol Сlin North Am. 2000; 13(3): 501-515. doi: 10.1016/s0896-1549(05)70210-8

8. Picht G, Welge-Luessen U, Grehn F, Lütjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001; 239(3): 199-207. doi: 10.1007/s004170000252

9. Zenkel M, Lewczuk P, Jünemann A, Kruse FE, Naumann GO, Schlötzer-Schrehardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol. 2010; 176(6): 2868-2879. doi: 10.2353/ajpath.2010.090914

10. Cone RE, Pais R. Anterior Chamber-Associated Immune Deviation (ACAID): An acute response to ocular insult protects from future immune-mediated damage? Ophthalmol Eye Dis. 2009; 1: 33-40. doi: 10.4137/oed.s2858

11. Fyodorov SN, Kozlov VI, Timoshkina NT. Non-penetrating deep sclerectomy for open-angle glaucoma. Fyodorov Journal of Ophthalmic Surgery. 1989; 3-4: 52-55. (In Russ.)

12. Goldsmith JA, Ahmed IK, Crandall AS. Nonpenetrating glaucoma surgery. Ophthalmol Clin North Am. 2005; 18(3): 443-460. doi: 10.1016/j.ohc.2005.05.008

13. Volkova NV, Iureva TN, Shchuko AG, Malyshev VV. Classification of intraocular fluid outflow pathways after fistulizing antiglaucomatous operations. National Journal glaucoma. 2008; 3: 16-20. (In Russ.)

14. Chekmareva LT, Iureva TN, Volkova NV. Topical localization of blocks in the outflow path by ultrasound biomicroscopy. Bulletin ESSC RAMS. 2000; 4: 20-22. (In Russ.)

15. Chester D, Brown AC. The role of biophysical properties of provisional matrix proteins in wound repair. Matrix Biol. 2017; 60-61: 124-140. doi: 10.1016/j.matbio.2016.08.004

16. Lama PJ, Fecthner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003; 48(3): 314-346. doi: 10.1016/s0039-6257(03)00038-9

17. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci. 2012; 53(1): 241-247. doi: 10.1167/iovs.11-8434

18. Yücel YH, Johnston MG, Ly T, Patel M, Drake B, Gümüş E, et al. Identification of lymphatics in the ciliary body of the human eye: A novel “uveolymphatic” outflow pathway. Exp Eye Res. 2009; 89(5): 810-819. doi: 10.1016/j.exer.2009.08.010

19. Akiyama G, Saraswathy S, Bogarin T, Pan X, Barron E, Wong TT, et al. Functional, structural, and molecular identification of lymphatic outflow from subconjunctival blebs. Exp Eye Res. 2020; 196: 108049. doi: 10.1016/j.exer.2020.108049

20. Huang AS, Penteado RC, Saha SK, Do JL, Ngai Ph, Hu Zh, et al. Fluorescein aqueous angiography in live normal human eyes. J Glaucoma. 2018; 27(11): 957-964. doi: 10.1097/IJG.0000000000001042